Literature DB >> 19933860

RasGRP1 is required for human NK cell function.

Suk Hyung Lee1, Sohyun Yun, Jiwon Lee, Mi Jeong Kim, Zheng-Hao Piao, Mira Jeong, Jin Woong Chung, Tae-Don Kim, Suk Ran Yoon, Philip D Greenberg, Inpyo Choi.   

Abstract

Cross-linking of NK activating receptors activates phospholipase-gamma and subsequently induces diacylglycerol and Ca(2+) as second messengers of signal transduction. Previous studies reported that Ras guanyl nucleotide-releasing protein (RasGRP) 1, which is activated by diacylglycerol and Ca(2+), is crucial for TCR-mediated Ras-ERK activation. We now report that RasGRP1, which can also be detected in human NK cells, plays an essential role in NK cell effector functions. To examine the role of RasGRP1 in NK cell functions, the expression of RasGRP1 was suppressed using RNA interference. Knockdown of RasGRP1 significantly blocked ITAM-dependent cytokine production as well as NK cytotoxicity. Biochemically, RasGRP1-knockdown NK cells showed markedly decreased ability to activate Ras, ERK, and JNK. Activation of the Ras-MAPK pathway was independently shown to be indispensable for NK cell effector functions via the use of specific pharmacological inhibitors. Our results reveal that RasGRP1 is required for the activation of the Ras-MAPK pathway leading to NK cell effector functions. Moreover, our data suggest that RasGRP1 might act as an important bridge between phospholipase-gamma activation and NK cell effector functions via the Ras-MAPK pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933860      PMCID: PMC2896689          DOI: 10.4049/jimmunol.0902012

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  Immune functions encoded by the natural killer gene complex.

Authors:  Wayne M Yokoyama; Beatrice F M Plougastel
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1.

Authors:  Trever G Bivona; Ignacio Pérez De Castro; Ian M Ahearn; Theresa M Grana; Vi K Chiu; Peter J Lockyer; Peter J Cullen; Angel Pellicer; Adrienne D Cox; Mark R Philips
Journal:  Nature       Date:  2003-06-29       Impact factor: 49.962

3.  Signal transduction: life on Mars, cellularly speaking.

Authors:  Pier Paolo Di Fiore
Journal:  Nature       Date:  2003-08-07       Impact factor: 49.962

4.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

5.  JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity.

Authors:  Changlin Li; Baoxue Ge; Matthew Nicotra; Joel N H Stern; Hernan D Kopcow; Xi Chen; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

6.  Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors.

Authors:  Ilaria Tassi; Rachel Presti; Sungjin Kim; Wayne M Yokoyama; Susan Gilfillan; Marco Colonna
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

7.  RasGRP is essential for mouse thymocyte differentiation and TCR signaling.

Authors:  N A Dower; S L Stang; D A Bottorff; J O Ebinu; P Dickie; H L Ostergaard; J C Stone
Journal:  Nat Immunol       Date:  2000-10       Impact factor: 25.606

8.  Direct tumor lysis by NK cells uses a Ras-independent mitogen-activated protein kinase signal pathway.

Authors:  S Wei; D L Gilvary; B C Corliss; S Sebti; J Sun; D B Straus; P J Leibson; J A Trapani; A D Hamilton; M J Weber; J Y Djeu
Journal:  J Immunol       Date:  2000-10-01       Impact factor: 5.422

9.  p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells.

Authors:  Ilaria Tassi; Marina Cella; Susan Gilfillan; Isaiah Turnbull; Thomas G Diacovo; Josef M Penninger; Marco Colonna
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

10.  Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.

Authors:  Hiromitsu Hara; Chitose Ishihara; Arata Takeuchi; Liquan Xue; Stephan W Morris; Josef M Penninger; Hiroki Yoshida; Takashi Saito
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

View more
  17 in total

1.  Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells.

Authors:  Husheng Ding; Jennifer S McDonald; Seongseok Yun; Paula A Schneider; Kevin L Peterson; Karen S Flatten; David A Loegering; Ann L Oberg; Shaun M Riska; Shengbing Huang; Frank A Sinicrope; Alex A Adjei; Judith E Karp; X Wei Meng; Scott H Kaufmann
Journal:  Haematologica       Date:  2013-08-30       Impact factor: 9.941

2.  Combined immunodeficiency with EBV positive B cell lymphoma and epidermodysplasia verruciformis due to a novel homozygous mutation in RASGRP1.

Authors:  Craig D Platt; Ari J Fried; Rodrigo Hoyos-Bachiloglu; G Naheed Usmani; Birgitta Schmidt; Jennifer Whangbo; Roberto Chiarle; Janet Chou; Raif S Geha
Journal:  Clin Immunol       Date:  2017-08-16       Impact factor: 3.969

3.  Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity.

Authors:  Tae-Don Kim; Su Ui Lee; Sohyun Yun; Hu-Nan Sun; Suk Hyung Lee; Jae Wha Kim; Hwan Mook Kim; Song-Kyu Park; Chang Woo Lee; Suk Ran Yoon; Philip D Greenberg; Inpyo Choi
Journal:  Blood       Date:  2011-09-29       Impact factor: 22.113

4.  In silico modeling identifies CD45 as a regulator of IL-2 synergy in the NKG2D-mediated activation of immature human NK cells.

Authors:  Sayak Mukherjee; Helle Jensen; William Stewart; David Stewart; William C Ray; Shih-Yu Chen; Garry P Nolan; Lewis L Lanier; Jayajit Das
Journal:  Sci Signal       Date:  2017-06-27       Impact factor: 8.192

5.  Cutting Edge: Murine NK Cells Degranulate and Retain Cytotoxic Function without Store-Operated Calcium Entry.

Authors:  Jacquelyn Freund-Brown; Ruth Choa; Brenal K Singh; Tanner Ford Robertson; Gabrielle M Ferry; Eric Viver; Hamid Bassiri; Janis K Burkhardt; Taku Kambayashi
Journal:  J Immunol       Date:  2017-08-09       Impact factor: 5.422

6.  RasGRP1 is essential for ras activation by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate in epidermal keratinocytes.

Authors:  Amrish Sharma; Courtney T Luke; Nancy A Dower; James C Stone; Patricia S Lorenzo
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

7.  Regulation and Function of the RasGRP Family of Ras Activators in Blood Cells.

Authors:  James C Stone
Journal:  Genes Cancer       Date:  2011-03

8.  Novel Mutations in RASGRP1 are Associated with Immunodeficiency, Immune Dysregulation, and EBV-Induced Lymphoma.

Authors:  Ido Somekh; Benjamin Marquardt; Yanshan Liu; Meino Rohlfs; Sebastian Hollizeck; Musa Karakukcu; Ekrem Unal; Ebru Yilmaz; Turkan Patiroglu; Murat Cansever; Shirly Frizinsky; Vicktoria Vishnvenska-Dai; Erez Rechavi; Tali Stauber; Amos J Simon; Atar Lev; Christoph Klein; Daniel Kotlarz; Raz Somech
Journal:  J Clin Immunol       Date:  2018-07-20       Impact factor: 8.317

9.  RasGRP Ras guanine nucleotide exchange factors in cancer.

Authors:  Olga Ksionda; Andre Limnander; Jeroen P Roose
Journal:  Front Biol (Beijing)       Date:  2013-10-01

Review 10.  The Impact of Immunodeficiency on NK Cell Maturation and Function.

Authors:  Alexander Vargas-Hernández; Lisa R Forbes
Journal:  Curr Allergy Asthma Rep       Date:  2019-01-19       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.